ImmunoGen Is Living Life in the Fast Lane
ImmunoGen Is Living Life in the Fast Lane
Filed under: drug treatment news articles
One of those stories emerged Tuesday when ImmunoGen (Nasdaq: IMGN ) and partner Roche (NASDAQOTH: RHHBY) announced that T-DM1, their experimental drug to treat HER2-positive breast cancer, has been awarded a priority review by the Food and Drug …
Read more on Motley Fool
Skin cancer patients find hope
Filed under: drug treatment news articles
Patients with an advanced form of skin cancer in the UK have found new hope after Britain's health watchdog reversed a decision to deny two drugs which could prolong life. The National Institute for Clinical Excellence (Nice) confirmed the treatment …
Read more on Sky News Australia
New analysis indicates that Novartis drug Gilenya shows significant early …
Filed under: drug treatment news articles
Basel, October 12, 2012 – New data will be presented at the 28th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) that reinforce the generally early and sustained efficacy benefit and long-term safety …
Read more on Reuters